Autoimmune hepatitis natural history, complications and prognosis

Revision as of 15:53, 20 December 2017 by Manpreet Kaur (talk | contribs)
Jump to navigation Jump to search

Autoimmune hepatitis Microchapters

Home

Patient Information

Overview

Historical Perspective

Classification

Pathophysiology

Causes

Differentiating autoimmune hepatitis differential diagnosis

Epidemiology and Demographics

Risk Factors

Screening

Natural History, Complications and Prognosis

Diagnosis

History and Symptoms

Physical Examination

Diagnostic of choice

Laboratory Findings

Electrocardiogram

X Ray

CT

MRI

Echocardiography or Ultrasound

Other Imaging Findings

Other Diagnostic Studies

Treatment

Medical Therapy

Surgery

Primary Prevention

Secondary Prevention

Cost-Effectiveness of Therapy

Future or Investigational Therapies

Case Studies

Case #1

Autoimmune hepatitis natural history, complications and prognosis On the Web

Most recent articles

Most cited articles

Review articles

CME Programs

Powerpoint slides

Images

American Roentgen Ray Society Images of Autoimmune hepatitis natural history, complications and prognosis

All Images
X-rays
Echo & Ultrasound
CT Images
MRI

Ongoing Trials at Clinical Trials.gov

US National Guidelines Clearinghouse

NICE Guidance

FDA on Autoimmune hepatitis natural history, complications and prognosis

CDC on Autoimmune hepatitis natural history, complications and prognosis

Autoimmune hepatitis natural history, complications and prognosis in the news

Blogs on Autoimmune hepatitis natural history, complications and prognosis

Directions to Hospitals Treating Autoimmune hepatitis

Risk calculators and risk factors for Autoimmune hepatitis natural history, complications and prognosis

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: :Manpreet Kaur, MD [2]

Overview

Natural History

Complications

Prognosis

  • The prognosis is generally thought to be inversely correlated with the histologic severity of disease.
  • Approximately 50% of patients will remain in remission or have only mild disease when steroids are withdrawn after the initial therapy.
  • Most patients, however, will require long-term maintenance therapy.

References

Template:WS Template:WH